GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:GSK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Dec 23	BuyUS$26,619	Vishal Sikka	Individual	727	US$36.62
20 Dec 23	BuyUS$8,348	Hal Barron	Individual	228	US$36.62
20 Dec 23	BuyUS$8,312	Harry Dietz	Individual	227	US$36.62
20 Dec 23	BuyUS$8,312	Anne Beal	Individual	227	US$36.62
20 Dec 23	BuyUS$64,333	Charles Bancroft	Individual	1,757	US$36.62
20 Dec 23	BuyUS$8,348	Elizabeth Anderson	Individual	228	US$36.62
20 Dec 23	BuyUS$8,312	Jesse Goodman	Individual	227	US$36.62
20 Sep 23	BuyUS$30,040	Vishal Sikka	Individual	790	US$38.03
20 Sep 23	BuyUS$8,328	Hal Barron	Individual	219	US$38.03
20 Sep 23	BuyUS$8,366	Harry Dietz	Individual	220	US$38.03
20 Sep 23	BuyUS$64,301	Charles Bancroft	Individual	1,691	US$38.03
20 Sep 23	BuyUS$8,328	Elizabeth Anderson	Individual	219	US$38.03
20 Sep 23	BuyUS$8,366	Jesse Goodman	Individual	220	US$38.03
20 Jun 23	BuyUS$30,016	Vishal Sikka	Individual	864	US$34.74
20 Jun 23	BuyUS$8,338	Hal Barron	Individual	240	US$34.74
20 Jun 23	BuyUS$8,338	Harry Dietz	Individual	240	US$34.74
20 Jun 23	BuyUS$8,338	Anne Beal	Individual	240	US$34.74
20 Jun 23	BuyUS$57,183	Charles Bancroft	Individual	1,646	US$34.74
20 Jun 23	BuyUS$8,338	Elizabeth Anderson	Individual	240	US$34.74
20 Jun 23	BuyUS$8,338	Jesse Goodman	Individual	240	US$34.74

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,876,139	0.0704%
Individual Insiders	4,580,779	0.112%
State or Government	8,424,577	0.206%
Private Companies	48,858,117	1.2%
Employee Share Scheme	82,340,591	2.02%
General Public	530,428,302	13%
Institutions	3,408,554,244	83.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.23%	Dodge & Cox	377,080,692	US$8.0b	-0.58%	3.5%
8.17%	BlackRock, Inc.	333,814,330	US$7.1b	-0.21%	0.12%
4.64%	The Vanguard Group, Inc.	189,450,566	US$4.0b	2.2%	0.07%
2.35%	State Street Global Advisors, Inc.	96,070,919	US$2.0b	1.91%	0.08%
2.21%	Norges Bank Investment Management	90,371,357	US$1.9b	-4.83%	0.16%
2.08%	Legal & General Investment Management Limited	84,809,119	US$1.8b	2.39%	0.36%
2.02%	GlaxoSmithKline Employee Trust	82,340,591	US$1.8b	31.4%	no data
1.64%	Schroder Investment Management Limited	67,162,712	US$1.4b	0.29%	0.91%
1.53%	UBS Asset Management AG	62,322,156	US$1.3b	4.39%	0.18%
1.36%	Silchester International Investors LLP	55,504,791	US$1.2b	0.15%	4.49%
1.32%	FMR LLC	53,986,854	US$1.1b	10.4%	0.07%
1.2%	Mondrian Investment Partners Limited	49,224,258	US$1.0b	0.16%	6.54%
1.19%	HSBC Global Asset Management (UK) Limited	48,492,384	US$1.0b	11%	0.52%
1.18%	GlaxoSmithKline plc, Shareview Client	48,094,521	US$1.0b	-0.9%	no data
1.11%	Columbia Management Investment Advisers, LLC	45,417,911	US$965.6m	5.21%	0.23%
1.04%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	42,407,746	US$901.6m	71%	22.93%
0.9%	Aviva Investors Global Services Ltd.	36,968,007	US$785.9m	1.13%	1.09%
0.83%	Wellington Management Group LLP	33,808,189	US$718.7m	-2.87%	0.11%
0.82%	Fisher Asset Management, LLC	33,317,889	US$708.3m	1.06%	0.33%
0.8%	Franklin Resources, Inc.	32,752,139	US$696.3m	4.69%	0.25%
0.75%	JP Morgan Asset Management	30,695,488	US$652.6m	3.51%	0.08%
0.74%	Causeway Capital Management LLC	30,220,101	US$642.5m	9.95%	2.7%
0.66%	Jupiter Fund Management Plc	26,807,896	US$569.9m	-1.48%	1.43%
0.65%	Amundi Asset Management SAS	26,651,354	US$566.6m	30.4%	0.12%
0.64%	T. Rowe Price Group, Inc.	26,192,730	US$556.8m	1.11%	0.05%